MedPath

Noninvasive Monitor of Vascular Volume Fluid Shifts

Not Applicable
Withdrawn
Conditions
Blood Loss
Interventions
Diagnostic Test: Thoracic impedance
Registration Number
NCT05080881
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Brief Summary

Blood volume measurements are a critical step in the emergency care of trauma patients. The typical approach to this is to rely on historical information, physical examination and metrics such as heart rate. There is currently no good real-time measure to track blood volume. This study investigates the use of phonocardiography (listening to the sounds made by the heart) to track changes in central blood volume.

Detailed Description

Blood draw subjects:

Participation in this study group may last up to 60 minutes. Participants will begin with a brief medical exam to determine eligibility. This will include a review of any history of cardiovascular disease and of medications. Prior to a scheduled blood draw, eligible participates will have physiological measurements taken, which may include phonocardiographic measurements, cardiac output, plethysmography (volume changes), multifrequency bioimpedance, thoracic impedance, heart rate, blood pressure, pulse oximetry, continuous non-invasive hematocrit measurement, and respiration. The phonocardiographic measurements may be taken with both a commercial and a custom-built device. These are all non-invasive measurements. After 15 minutes of baseline measurements, a blood draw will proceed normally while the physiological measurements continue. After the participant is finished donating blood, the participant will be asked to stay in place for an additional 15 minutes to continue to collect physiological data. Participants are asked not to eat or drink during the 15 minutes as this will provide better data collection. The information collected as data for this study includes: information about medical history, body measurements, and physiological measurements.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • In generally good health
  • Free of systemic diseases
  • No contraindications to LBNP exposure.
  • No prior history of cardiovascular disease
  • Normal resting systolic blood pressure (SBP, 100-140 mm Hg) and diastolic blood pressure (DBP, 60-90 mm Hg).
Exclusion Criteria
  • Individuals who, after lying supine for five minutes, show a greater than 10 mm Hg drop in systolic pressure or a greater than 20 beats/minute increase in heart rate with standing during pre-enrollment evaluation

Blood draw participants:

Inclusion Criteria:

  • In generally good health
  • Free of systemic diseases
  • No current or prior history of cardiovascular disease or cardiovascular reactive drugs
  • Blood donors through the DHMC blood donation center
  • Healthy volunteers
  • People who are taking part in another study where about 500 ml of blood is being drawn
  • Therapeutic phlebotomy patients (hemochromatosis or polycythemia vera patients)

Exclusion Criteria:

  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood drawThoracic impedanceAll blood draw subjects will have baseline data collected over 15 minutes. The participants with then donate blood. For 15 minutes after the blood donation, the participant will stay in place and will continue to have data collected.
Primary Outcome Measures
NameTimeMethod
Change in phonographic characteristics - frequencyThrough study completion; 3 hours

Frequency content of cardiac tones

Change in phonographic characteristics - amplitudeThrough study completion; 3 hours

Size of cardiac systolic and diastolic heart tones

Change in cardiac cycle time intervalsThrough study completion; 3 hours

Cardiac systolic and diastolic times

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath